This one is going back to low 20's before long.
Much has been made up about its prospects but so was SSH and have a look at them now.
Fact is that Epitan has been promising plenty and delivered little like so many in the medical field.
They have no earnings, its only a matter of time before they issue more paper .
epitan - commercialisation contract, page-2
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.41 |
Change
1.510(10.9%) |
Mkt cap ! $771.6M | |||
| Open | High | Low | Value | Volume |
| $14.14 | $15.64 | $14.14 | $4.103M | 269.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14 | $15.37 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.42 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| CUV (ASX) Chart |